Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 2
150
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The Relationship between PTPN22 R620W Polymorphisms and the Susceptibility to Autoimmune Thyroid Diseases: An Updated Meta-analysis

, , , , & ORCID Icon

References

  • Abdennaji Guenounou B, Loueslati BY, Buhler S, Hmida S, Ennafaa H, Khodjet-Elkhil H, Moojat N, Dridi A, Boukef K, Ben Ammar Elgaaied A, et al. 2006. HLA class II genetic diversity in southern Tunisia and the Mediterranean area. Int J Immunogenet. 33(2):93–103.
  • Alkhateeb A, Marzoukan A, Tashtoush R. 2013. Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population. Endocrine. 44(3):702–09.
  • Alswat KA, Nasr A, Al Dubayee MS, Talaat IM, Alsulaimani AA, Mohamed IAA, Allam G. 2018. The potential role of PTPN-22 C1858T gene polymorphism in the pathogenesis of type 1 diabetes in Saudi population. Immunol Invest. 47(5):521–33.
  • Athanasiadis G, Esteban E, Via M, Dugoujon JM, Moschonas N, Chaabani H, Moral P. 2007. The X chromosome Alu insertions as a tool for human population genetics: data from European and African human groups. Eur J Hum Genet. 15(5):578–83.
  • Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. 2005. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid. 15(10):1115–18.
  • Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 75(2):330–37.
  • Bulut F, Erol D, Elyas H, Doğan H, Ozdemir FA, Keskin L. 2014. Protein tyrosine phosphatase non-receptor 22 gene C1858T polymorphism in patients with coexistent type 2 diabetes and Hashimoto’s thyroiditis. Balkan Med J. 31(1):37–42.
  • Cambier JC. 2013. Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways. J Clin Invest. 123(5):1928–31.
  • Chabchoub G, Teixiera EP, Maalej A, Ben Hamad M, Bahloul Z, Cornelis F, Ayadi H. 2009. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann Hum Biol. 36(3):342–49.
  • De Jager PL, Sawcer S, Waliszewska A, Farwell L, Wild G, Cohen A, Langelier D, Bitton A, Compston A, Hafler DA, et al. 2006. Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn’s disease and multiple sclerosis. Eur J Hum Genet. 14(3):317–21.
  • Dultz G, Matheis N, Dittmar M, Röhrig B, Bender K, Kahaly GJ. 2009. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid. 19(2):143–48.
  • Feng M, Zhang FB, Deng HR. 2013. The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto’s thyroiditis in Asian but not Caucasian populations: an updated meta-analysis. Endocrine. 44(2):350–58.
  • Fousteri G, Liossis SN, Battaglia M. 2013. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity. Clin Immunol. 149(3):556–65.
  • Ghorban K, Ezzeddini R, Eslami M, Yousefi B, Sadighi Moghaddam B, Tahoori MT, Dadmanesh M, Salek Farrokhi A. 2019. PTPN22 1858 C/T polymorphism is associated with alteration of cytokine profiles as a potential pathogenic mechanism in rheumatoid arthritis. Immunol Lett. 216:106–13.
  • Gu LQ, Zhu W, Zhao SX, Zhao L, Zhang MJ, Cui B, Song HD, Ning G, Zhao YJ. 2010. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves’ disease. Clin Endocrinol. 72(2):248–55.
  • Hamza RT, Awwad KS, Temsah KA, Hamed AI. 2013. R620W polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity. Int J Adolesc Med Health. 25(2):143–49.
  • Heward JM, Brand OJ, Barrett JC, Carr-Smith JD, Franklyn JA, Gough SC. 2007. Association of PTPN22 haplotypes with Graves’ disease. J Clin Endocrinol Metab. 92(2):685–90.
  • Hwangbo Y, Park YJ. 2018. Genome-wide association studies of autoimmune thyroid diseases, thyroid function, and thyroid cancer. Endocrinol Metab. 33(2):175–84.
  • Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y. 2008. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves’ disease in a Japanese population. Thyroid. 18(6):625–30.
  • Jin X, Guan Y, Shen H, Pang Y, Liu L, Jia Q, Meng F, Zhang X. 2018. Copy number variation of immune-related genes and their association with iodine in adults with autoimmune thyroid diseases. Int J Endocrinol. 2018:1705478.
  • Jung JH, Song GG, Kim JH, Choi SJ. 2016. Association of interleukin 10 gene polymorphisms with autoimmune thyroid disease: meta-analysis. Scand J Immunol. 84(5):272–77.
  • Kahles H, Ramos-Lopez E, Lange B, Zwermann O, Reincke M, Badenhoop K. 2005. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto’s thyroiditis or Addison’s disease in the German population. Eur J Endocrinol. 153(6):895–99.
  • Lee HJ, Li CW, Hammerstad SS, Stefan M, Tomer Y. 2015. Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J Autoimmun. 64:82–90.
  • Li M, Sun H, Liu S, Yu J, Li Q, Liu P, Shen H, Sun D. 2012. CD40 C/T-1 polymorphism plays different roles in Graves’ disease and Hashimoto’s thyroiditis: a meta-analysis. Endocr J. 59(12):1041–50.
  • Liu XC, Guo XH, Chen X, Yao Y. 2020. Toll-like receptor 4 gene polymorphisms rs4986790 and rs4986791 and age-related macular degeneration susceptibility: a meta-analysis. Ophthalmic Genet. 41(1):31–35.
  • López-Cano DJ, Cadena-Sandoval D, Beltrán-Ramírez O, Barbosa-Cobos RE, Sánchez-Muñoz F, Amezcua-Guerra LM, Juárez-Vicuña Y, Aguilera-Cartas MC, Moreno J, Bautista-Olvera J, et al. 2017. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves’ disease in a Mexican population. Inflamm Res. 66(9):775–81.
  • McLeod DS, Cooper DS. 2012. The incidence and prevalence of thyroid autoimmunity. End Moravvej Ocrine. 42(2):252–65.
  • Moravvej H, Tabatabaei-Panah PS, Abgoon R, Khaksar L, Sokhandan M, Tarshaei S, Ghaderian SMH, Ludwig RJ, Akbarzadeh R. 2018. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata. Immunol Invest. 47(7):666–79.
  • Nikitin Y, Rymar O, Maksimov V, Simonova G, Zankina M, Mustafina S, Sherbakova L, Chernova N, Voevoda M. 2009. Association of PTPN22 haplotypes with hashimotos thyroiditis in population of novosibirsk. Kliniceskaâ I Èksperimental’naâ Tireoidologiâ. 1:47–52.
  • Ouchari M, Romdhane H, Chakroun T, Abdelkefi S, Jarrey I, Houissa B, Jemni Yacoub S. 2015. The Duffy blood group system in the Tunisian population. Transfus Clin Biol. 22(2):76–79.
  • Raslan HM, Attia HR, Salama I, Ibrahim MH, Hassan EM, El Hussieny MS, El Menyawi MM, Amr KS. 2016. Association of PTPN22 1858C–>T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis. Rheumatolo Int. 36(8):1167–75.
  • Shen H. 2005. Global epidemic of iodine deficiency disorders. Chin J Epidemiol. 05:119–21.
  • Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R. 2005. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves’ disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf). 62(6):679–82.
  • Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, et al. 2004. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 53(11):3020–23.
  • Törn C, Hadley D, Lee HS, Hagopian W, Lernmark Å, Simell O, Rewers M, Ziegler A, Schatz D, Akolkar B, et al. 2015. Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes. 64(5):1818–29.
  • Vang T, Congia M, Macis MD, Musumeci L, Orrú V, Zavattari P, Nika K, Tautz L, Taskén K, Cucca F, et al. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet. 37(12):1317–19.
  • Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, et al. 2004. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab. 89(11):5862–65.
  • Wang S, Yao Y. 2017. Correlation between protein tyrosine phosphatase non-receptor 22 (PTPN-22) gene polymorphism and Tibetan Graves disease in Qinghai. Chin J Epidemiol. 36(9):635–38.
  • Wang S, Zhao Z, Jiang X, Cui B, Jia H, Zhao Y, Ning G. 2007. Relationship between LYP/PTPN22 and Graves disease in Shanghai Han population in China. J Shanghai Jiaotong Univ. 27(8):984–86.
  • Watanabe A, Inoue N, Watanabe M, Yamamoto M, Ozaki H, Hidaka Y, Iwatani Y. 2020. Increases of CD80 and CD86 expression on peripheral blood cells and their gene polymorphisms in autoimmune thyroid disease. Immunol Invest. 49(1–2):191–203.
  • Wawrusiewicz-Kurylonek N, Koper-Lenkiewicz OM, Gościk J, Myśliwiec J, Pawłowski P, Krętowski AJ. 2019. Association of PTPN22 polymorphism and its correlation with Graves’ disease susceptibility in Polish adult population—A preliminary study. Mol Genet Genomic Med. 7(6):e661.
  • Wu H, Cantor RM, Graham DS, Lingren CM, Farwell L, Jager PL, Bottini N, Grossman JM, Wallace DJ, Hahn BH, et al. 2005. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased t allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum. 52(8):2396–402.
  • Yamamoto M, Watanabe M, Inoue N, Watanabe A, Ozaki H, Ohsaki M, Hidaka Y, Iwatani Y. 2020. Association of CD58 polymorphisms and its protein expression with the development and prognosis of autoimmune thyroid diseases. Immunol Invest. 49(1–2):106–19.
  • Ye J, Ren A. 2015. Relationship between PTPN22 gene polymorphism and Graves disease in Han population in Anhui. China J Mod Med. 25(7):44–46.
  • Zhang Z, Zheng X, Yang T. 2016. Progress in clinical research of autoimmune thyroid disease. Drug Eval. 13(1):9–13.
  • Zheng R, Zhang S, Li R, Wang Z, Wang M, Wan X, Liang S. 2008. Association between PTPN22 gene polymorphisms and Graves disease in Han people of Chongqing area. J Chongqing Med Univ. 33(1):22–24+28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.